MicroRNA in Solid Tumor and Hematological Diseases

• Autres auteurs: Lovat, Francesca (Éditeur intellectuel)
• Format: Électronique Chapitre de livre
• Langue: anglais
• Publié: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• Sujets: Research & information: general; bladder cancer; urine; miRNA; reference miRNA; normalizer; RT-qPCR; miR-139-5p; miR-139-3p; renal cell carcinoma (RCC); microRNA; tumor suppressor; paxillin (PXN); acute myeloblastic leukemia; acute lymphoblastic leukemia; colorectal cancer; amino acid transporters; LAT1; ASCT2; miRNAs; microRNAs; GI cancers; targeted therapy; drug resistance; miR-7; gene expression; cancer cell; prognosis; follicular lymphoma; marginal zone lymphoma; Waldenström's macroglobulinemia; hairy cell leukemia; primary cutaneous follicle center lymphoma; normal B-cell development; therapeutic target; diagnosis; solid cancer; post-transcriptional regulation; hepatocellular carcinoma; Hippo kinase; Yes-associated protein; liver disease; cancer therapy; PDAC; survival; expression profiling; ovarian cancer; epithelial ovarian cancer; liquid biopsy; circulating miRNAs; drug response; personalized medicine; chemotherapy; n/a
• Accès en ligne: DOAB: download the publication; DOAB: description of the publication

MicroRNAs (miRNAs), which are a type of short non-coding RNA, are involved in number of processes, such as differentiation, development, inflammation, immune response, and cancer. miRNAs, which act as oncogenes or tumor suppressor genes, can control and regulate the translation and stability of targ...